• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Hemophilia A
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Hemophilia A trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Hemophilia A research

While the standard of care has advanced dramatically, new discoveries and approaches offer opportunities to develop better hemophilia A treatments. Signant Health can apply decades of deep therapeutic-area, pediatric, and rare disease expertise, as well as innovative clinical trial technologies within our Signant SmartSignals suite to help researchers support hemophilia A study endpoints.

 
Hemo A-1

Why Signant Health

  • Streamline COA Management
  • Minimize Participation Burdens
  • Simplify Medication Management
  • Gain Expert Guidance
  • Streamline COA Management

    Streamline COA Management

    With many types and versions of home- and site-based clinical outcome assessments involved in hemophilia A trials, capturing accurate, reliable COA data can be challenging. Leverage our comprehensive eCOA platform and our scientific expertise to simplify COA administration, reduce patient burdens, optimize data quality, and launch studies quickly.
     
     
     
     

  • Minimize Participation Burdens

    Minimize Participation Burdens

    Make study participation more convenient for patients and caregivers. With eConsent, patients can take their time reviewing study requirements at home before making the effort to visit the clinic. Once enrolled, leverage video-assisted patient engagement to connect with patients and caregivers between visits for safety monitoring and regular checkups. 
     
     
     

  • Simplify Medication Management

    Simplify Medication Management

    Take control of inventory management for numerous medications and simplify randomization for multi-arm trial designs with Signant's global RTSM solution. Our agile design process will help you launch quickly and manage mid-study changes with ease. Plus, a dedicated team experienced in hemophilia A protocols will support your trial operations from study launch to database lock.
     
     

  • Gain Expert Guidance

    Leverage our Hematology Research Experts

    From consulting on outcome measure selection and implementation to reducing burdens on sites and patients, Signant’s in-house experts will help you navigate study design and operational challenges throughout the study lifecycle. Talk through your protocol with our full-time clinical science and medicine experts experienced in hematology, rare disease, and pediatric studies.
     
     
     
     

Comprehensive Hematology experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Hemophilia A trial resources
SOLUTION BROCHURE

Hemophilia A Trial Solutions Overview

GET INSIGHTS
VIDEO

Hemophilia A Trial Solutions


WATCH [2 MIN]
SOLUTION

Patient Engagement

 
LEARN MORE

eClinical solutions for Hemophilia A trials

Ready to learn more?

Discover how Signant can support your current or upcoming Hemophilia A trials. 

DOWNLOAD BROCHURE GET STARTED